Mar 9, 2023 04:00PM
Jan 8, 2023 03:00PM
Oct 27, 2022 04:00PM
Oct 27, 2022 04:00PM
Sep 11, 2022 09:00PM
Sep 6, 2022 09:26PM
Aug 31, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Molecular Partners, TG Therapeutics, 17EdTech, and Enochian and Encourages Investors to Contact the Fir
Aug 26, 2022 09:00PM
Aug 25, 2022 04:30PM
Aug 21, 2022 09:00PM
Aug 15, 2022 09:00PM
Aug 10, 2022 09:00PM
Aug 5, 2022 09:00PM
Jul 31, 2022 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Missfresh, Molecular Partners, TG Therapeutics, and 17EdTech and Encourages Investors to Contact the Fi
Jul 25, 2022 09:00PM
Jul 21, 2022 11:31AM
Jul 21, 2022 11:30AM
Jul 20, 2022 09:00PM
Jul 15, 2022 09:00PM
May 12, 2022 04:05PM
Apr 26, 2022 02:11PM Molecular Partners AG (MOLN) Provides Update on Ensovibep Following Novartis Quarterly Earnings Call
Apr 26, 2022 02:00PM
Mar 15, 2022 04:30PM
Feb 10, 2022 04:41AM
Feb 10, 2022 01:00AM
Jan 10, 2022 05:35AM
Jan 10, 2022 01:17AM
Aug 26, 2021 01:00AM Molecular Partners Reports Corporate Highlights and Key Financials for H1 2021
Oct 14, 2019 06:13AM
Oct 11, 2019 07:40PM
Sep 9, 2019 07:30AM
Apr 2, 2019 07:05AM
Apr 2, 2019 07:00AM
Dec 18, 2018 11:00PM
Jul 19, 2018 08:02AM Allergan (AGN), Molecular Partners Announce Two Positive Phase 3 Clinical Trials for Abicipar pegol 8 and 12-week Regimens for Treatment in Patients with Neovascular AMD
Jul 19, 2018 08:00AM
Sep 19, 2017 04:00AM

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All